420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism

Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

GW Pharmaceuticals grows the cannabis to be used during the research. The company occupies 47-plus acres in the English countryside and is the first drug company to develop cannabis-related medicine which was approved by the U.S. Food and Drug Administration. Two rare types of epilepsy are treated using…


About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

Leave a Reply